Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Technology in Cancer Research & Treatment|October 28, 2025
Abbreviated MRI Screening in Turkish Women Aged 40-69 With Dense Breasts: A Prospective Feasibility StudyInci Kizildag Yirgin, Neslihan Cabioglu, Memduh Dursun, et al.
Annals of Surgical Oncology|January 30, 2007
Role for intraoperative margin assessment in patients undergoing breast-conserving surgeryNeslihan Cabioglu, Kelly K Hunt, Aysegul A Sahin, et al.
World Journal of Surgical Oncology|October 31, 2024
Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapyMahmut Muslumanoglu, Baran Mollavelioglu, Neslihan Cabioglu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2020
The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01QAtilla Soran, Aykut Soyder, Serdar Ozbas, et al.
Cancers|February 25, 2023
Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)Maggie Banys-Paluchowski, Thorsten Kühn, Yazan Masannat, et al.
Annals of Surgical Oncology|February 3, 2021
The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry StudyAtilla Soran, Lutfi Dogan, Arda Isik, et al.
Annals of Surgical Oncology|May 20, 2018
Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01Atilla Soran, Vahit Ozmen, Serdar Ozbas, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1aAtilla Soran, Berk Göktepe, Berkay Demirors, et al.
JAMA Surgery|January 2, 2025
De-Escalation of Nodal Surgery in Clinically Node-Positive Breast CancerNeslihan Cabioglu, Havva Belma Koçer, Hasan Karanlik, et al.
Cancer|October 30, 2024
Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is providedMahmut Muslumanoglu, Neslihan Cabioglu, Abdullah Igci, et al.
Pageof 8